Invest with Confidence
GLG helps healthcare investors stay ahead of trends in therapies, devices, and diagnostic tools by connecting them with the largest and most varied network of key opinion leaders in the healthcare industry.
What We Do
Get the first-hand insights you need to evaluate healthcare investment opportunities.
Pharmaceuticals and Biotechnology
Tap into the largest network of healthcare key opinion leaders – including researchers, physicians, and executives – who can help you stay informed on drug discovery, clinical trials, and treatment paradigms.
Health Services and Policy Research
Gain insights into the various healthcare services sectors, ranging from technology and the pharma supply chain to regulatory policy and outsourced services, by connecting with specialists such as payors, hospital executives, and former policymakers.
Medical Devices and Diagnostics
Take advantage of the most extensive network of seasoned medical professionals and technology executives to stay on top of the evolution of data, systems, and platforms within medical devices and diagnostics.
GLG provides coverage of topics discussed at live and virtual conferences. Our events allow you to learn from leading experts and peers about industry trends.
Uncovering Needs in the Medical Scrubs
CASE STUDY
A public investor needed to accurately assess the medical scrubs market before making an investment decision. GLG facilitated dozens of calls with both current and former industry experts, surveyed nearly 1,000 healthcare professionals, and developed and ran concept tests to identify purchase drivers and key preferences.
Due Diligence: Assessing a New Treatment
CASE STUDY
A biopharmaceutical company wanted to gather unbiased opinions on the results of its early clinical development from leading key opinion leaders in the oncology field. GLG provided product development direction by connecting the client with top oncologists in the U.S.
Real-Time COVID-19 Consumer Impact
CATEGORY
A GLG client needed real-time insight into unemployment statistics, consumer spending habits, and consumer sentiment to understand the immediate implications for holdings in its portfolio. GLG Surveys designed and executed a 10-wave survey series that helped the client understand a rapidly evolving situation.
The GLG Difference
Real-World Expertise
GLG has approximately 1 million Network Members across the globe, including more than 180,000 healthcare experts such as physicians, specialists, researchers, executives, emerging market experts, payors, and regulatory professionals.
A Trusted Environment
Our teams use industry-leading compliance protocols. We’ve built a safe and trusted environment for Network Members and clients to help protect them from exposing, or being exposed to, confidential information.
Personalized Service
Our service professionals and market research experts work with your team to create a tailored research approach, helping you get answers to your most pressing questions.
Biogen’s Aduhelm: Rollout Update
Article
Dr. Anton Porsteinsson, Director of the Alzheimer’s Disease Care, Research and Education Program at the University of Rochester, addresses outstanding questions after the FDA approval of Biogen’s Aduhelm.
GLG Institute’s 2021 Healthcare Summit
Article
GLG’s 2021 Healthcare Leadership Summit created an open forum to discuss ways we can collaborate and broaden our community to improve the efficacy of healthcare for generations to come.
Biden’s Healthcare Priorities
Article
GLG’s Virtual Healthcare Leadership Convene heard from our Network Members about a range of topics, including the state of COVID-19 in Europe, and President Biden’s healthcare agenda.
Contact Us
Enter your contact information and a member of our team will reach out to you shortly.